Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 22 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

22 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
June 9, 2008 BGMS P 100 $2.11 $211 46,268 Direct +0.22% Acquired -100.0% (price as of )
June 9, 2008 BGMS P 100 $2.14 $214 46,368 Direct +0.22% Acquired -100.0% (price as of )
June 9, 2008 BGMS P 400 $2.13 $852 46,768 Direct +0.86% Acquired -100.0% (price as of )
June 9, 2008 BGMS P 362 $2.14 $775 47,130 Direct +0.77% Acquired -100.0% (price as of )
June 9, 2008 BGMS P 38 $2.13 $81 47,168 Direct +0.08% Acquired -100.0% (price as of )
June 9, 2008 BGMS P 1,000 $2.14 $2,140 48,168 Direct +2.12% Acquired -100.0% (price as of )

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Dec. 5, 2019 BGMS Option Common Stock (11,067) $1.74 Dec. 29, 2027 11,067 Acquired
Dec. 5, 2019 BGMS Option Common Stock (10,182) $1.56 Feb. 22, 2028 10,182 Acquired
Jan. 4, 2019 BGMS Option Common Stock (284,592) $0.71 Jan. 4, 2029 284,592 Acquired
Jan. 3, 2019 BGMS Option Common Stock (11,068) $1.74 Dec. 29, 2027 11,068 Acquired
Jan. 3, 2019 BGMS Option Common Stock (10,183) $1.56 Feb. 22, 2028 10,183 Acquired
Dec. 7, 2015 BGMS Option Common Stock (229,858) $0.59 Dec. 7, 2025 229,858 Acquired
Feb. 18, 2015 BGMS Option Common Stock (42,940) $0.86 Feb. 18, 2025 42,940 Acquired
Dec. 9, 2013 BGMS Option Common Stock (65,000) $4.61 Dec. 9, 2023 65,000 Acquired
Dec. 10, 2010 BGMS Option Common Stock (62,500) $1.59 Dec. 10, 2020 62,500 Acquired
Nov. 18, 2008 BGMS Option Common Stock (75,000) $0.44 Nov. 18, 2018 75,000 Acquired
Nov. 18, 2008 BGMS Option Common Stock (75,000) $0.44 Nov. 18, 2018 75,000 Acquired
Nov. 18, 2008 BGMS Restricted Stock Units Common Stock (25,000) · · 25,000 Acquired
Dec. 6, 2007 BGMS Option Common Stock (100,000) $5.53 Dec. 6, 2017 100,000 Acquired
Dec. 21, 2006 BGMS Option Common Stock (80,000) $6.95 Dec. 20, 2016 80,000 Acquired
June 14, 2006 BGMS Common Stock Option Common Stock (48,967) $6.40 June 14, 2016 48,967 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 29, 2006 BGMS Common Stock, par value $0.001 per share 0 Direct
March 29, 2006 BGMS 6% Convertible Exchange Pref Stock par $0.001 per share 0 Direct

Annual statements (Form 5) Transactions and holdings reported once a year on SEC Form 5 — exempt or late-reported trades, gifts and small acquisitions.

09

Transactions (1)

DateTickerSecurityCodeShares PriceValueOwned afterExercise priceExpirationA/D
Dec. 6, 2014 BGMS Common Stock, $0.001 par value per share F 3,112 $2.99 $9,305 58,008 · · ·

Compensation (DEF 14A)

10

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BGMS

MD Vice President, Clinical Development and Regulatory Affairs
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2018 $371,389 $67,073 · $41,854 · · $49,417 $529,733
2017 $371,389 $103,989 · $15,914 · · $46,867 $538,159
2016 $360,572 $93,749 · $0 · · $30,455 $484,776

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.